Bausch Health Companies
Presencia
Bausch Health Companies es una de las ...
Bausch Health Companies es una empresa que cotiza bajo el símbolo de cotización BHC (CA).
Bausch Health Companies tiene presencia directa en 7 países.Bausch Health Companies posee 10 subsidiarias incluyendo Bausch & Lomb, Bausch & Lomb France y Bausch & Lomb Germany.
Ellos se encuentran en:
- Equipos médicos64%
- Farmacia27%
- Otro9%
Ejecutivos
Ver el organigrama con sus 104 ejecutivos principales
Biografías más buscadas en Bausch Health Companies
- Thomas Appio, Chief Executive Officer and Director
- Robert Power, Chairman Designate
- Thomas Ross, Director
Recientes movimientos de ejecutivos en Bausch Health Companies
- Tom Vadaketh, Executive Vice President and Chief Financial Officer, abandonará la empresa el 13 de oct.. de 2023 (noticia publicada el 19 de septiembre de 2023).
Crear su alerta
para seguir los movimientos de los ejecutivos en Bausch Health Companies.
Farmacia
Bausch Health Companies tiene 1.863 competidores entre los que se incluyen Pfizer (Estados Unidos), Johnson & Johnson (Estados Unidos) y Sanofi (Francia).
Popular M&A news in Farmacia
- Revolution Medicines ha Eqrx adquirido (publicado el 10 de noviembre de 2023).
- Cybin ha Small Pharma adquirido (publicado el 24 de octubre de 2023).
- Horizon Therapeutics and Amgen have announced they will merge (publicado el 10 de octubre de 2023)..
Otros contactos sugeridos en el sector Farmacia
Noticias
Últimos comunicados de prensa de Bausch Health Companies
- Salix In Collaboration With The U.S. Pain Foundation And The International Foundation For Gastrointestinal Disorders Establish The Inaugural Opioid- Induced Constipation (Oic) Awareness Day
- The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis
- As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD)
- As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD)
- The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis
- Bausch Health Announces Third-Quarter 2023 Results
- Bausch Health Announces Third-Quarter 2023 Results
- U.S. District Court Dismisses Norwich’s Lawsuit Against the FDA
- Bausch Health Unveils "Looking Forward" – A New DTC Television Campaign for Seasonal Affective Disorder (SAD)
- Bausch Health to Announce Third-Quarter 2023 Results on Nov. 2
- View more press releases Close
Redes sociales sobre Bausch Health Companies
- Bausch Health Companies en Wikipedia, Google News y Yahoo Finance
- Bausch Health Companies en LinkedIn, Twitter y YouTube
Ponerse en contacto
Contactar a través de e-mail con sus ejecutivos Thomas Appio 
Llame a Bausch Health Companies al +1 866...
